Cyprien Shyirambere
Biographic Data
| ID | 7753954 |
|---|---|
| NAME | Cyprien Shyirambere |
| GIVEN NAMES | Cyprien |
| FAMILY NAME | Shyirambere |
| SIGNATURE | SHYIRAMBERE C |
| AFFILIATIONS | Partners In Health |
| ORCID | 0000-0002-3203-3873 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Weak economic evidence for WHO’s essential cancer medicines for Africa
INTRODUCTION: The WHO Model Lists of Essential Medicines (MLEM and MLEMc) guide national medicine selection, particularly in low-income and lower middle-income countries (LMICs). Concerns exist about the adequacy and transferability of economic evidence supporting recent cancer medicine additions. METHODS: We systematically examined modifications to cancer medicines on the WHO MLEM(c) between 2017 and 2023 and assessed their adoption into Nationa…
Perioperative outcomes at three rural Rwandan district hospitals
INTRODUCTION: The paucity of data on perioperative outcomes in low- and middle-income countries complicates the design and implementation of targeted interventions to improve the delivery of safe, affordable, accessible and timely surgical and anaesthesia care services. We assessed perioperative outcomes of patients undergoing surgical care at three Rwandan rural hospitals-Butaro District Hospital, Kirehe District Hospital and Rwinkwavu District …
Impact of facilitating continued accessibility to cancer care during Covid-19 lockdown on perceived wellbeing of cancer patients at a rural cancer center in Rwanda
During the COVID-19 pandemic in Rwanda, Partners In Health Inshuti Mu Buzima collaborated with the Butaro Cancer Center of Excellence (BCCOE) to mitigate disruptions to cancer care by providing patients with free transportation to treatment sites and medication delivery at patients’ local health facilities. We assessed the relationship between facilitated access to care and self-reported wellbeing outcomes. This cross-sectional telephone survey i…
Procedural fairness for radiotherapy priority setting in a low resource context
Radiotherapy is an essential component of cancer treatment, yet many countries do not have adequate capacity to serve their populations. This mismatch between demand and supply creates the need for priority setting. There is no widely accepted system to guide patient prioritization for radiotherapy in a low resource context. In the absence of consensus on allocation principles, fair procedures for priority setting should be established. Research …
Cancer care delivery innovations, experiences and challenges during the Covid-19 pandemic
We would like to thank the Rwandan Ministry of Health, Ministry of Local Government and the Rwanda National Police that promptly responded to and supported the implementation of these different strategies.Additionally, we
Barriers and coping mechanisms to accessing healthcare during the Covid-19 lockdown
A large proportion of chronic care patients experienced barriers to accessing healthcare during the COVID-19 lockdown. However, many patients also independently identified positive coping mechanisms to ensure continuation of care - strategies that could be formally adopted by healthcare systems in Rwanda and similar settings to mitigate effects of future lockdowns on patients
No prominent works on this page.
Cancer care delivery innovations, experiences and challenges during the Covid-19 pandemic
We would like to thank the Rwandan Ministry of Health, Ministry of Local Government and the Rwanda National Police that promptly responded to and supported the implementation of these different strategies.Additionally, we
Barriers and coping mechanisms to accessing healthcare during the Covid-19 lockdown
A large proportion of chronic care patients experienced barriers to accessing healthcare during the COVID-19 lockdown. However, many patients also independently identified positive coping mechanisms to ensure continuation of care - strategies that could be formally adopted by healthcare systems in Rwanda and similar settings to mitigate effects of future lockdowns on patients
Procedural fairness for radiotherapy priority setting in a low resource context
Radiotherapy is an essential component of cancer treatment, yet many countries do not have adequate capacity to serve their populations. This mismatch between demand and supply creates the need for priority setting. There is no widely accepted system to guide patient prioritization for radiotherapy in a low resource context. In the absence of consensus on allocation principles, fair procedures for priority setting should be established. Research …
Impact of facilitating continued accessibility to cancer care during Covid-19 lockdown on perceived wellbeing of cancer patients at a rural cancer center in Rwanda
During the COVID-19 pandemic in Rwanda, Partners In Health Inshuti Mu Buzima collaborated with the Butaro Cancer Center of Excellence (BCCOE) to mitigate disruptions to cancer care by providing patients with free transportation to treatment sites and medication delivery at patients’ local health facilities. We assessed the relationship between facilitated access to care and self-reported wellbeing outcomes. This cross-sectional telephone survey i…
Perioperative outcomes at three rural Rwandan district hospitals
INTRODUCTION: The paucity of data on perioperative outcomes in low- and middle-income countries complicates the design and implementation of targeted interventions to improve the delivery of safe, affordable, accessible and timely surgical and anaesthesia care services. We assessed perioperative outcomes of patients undergoing surgical care at three Rwandan rural hospitals-Butaro District Hospital, Kirehe District Hospital and Rwinkwavu District …
Weak economic evidence for WHO’s essential cancer medicines for Africa
INTRODUCTION: The WHO Model Lists of Essential Medicines (MLEM and MLEMc) guide national medicine selection, particularly in low-income and lower middle-income countries (LMICs). Concerns exist about the adequacy and transferability of economic evidence supporting recent cancer medicine additions. METHODS: We systematically examined modifications to cancer medicines on the WHO MLEM(c) between 2017 and 2023 and assessed their adoption into Nationa…
Medicine (4 works) · COVID-19 and healthcare impacts (3 works) · Internal Medicine (3 works) · Nursing (3 works) · 2019-20 coronavirus outbreak (2 works) · Cancer (2 works) · Economic and Financial Impacts of Cancer (2 works) · Family medicine (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Logistic regression (2 works)